-
Dr. Christian Chabannon: The Era of Personalized Immunotherapy from a European Perspective
Recently, the 11th Sino-French Hematology Academic Conference, organized by the Chinese Medical Doctor Association, was successfully held in Tianjin, China, attracting hundreds of top experts and scholars in the field of hematology from both China and abroad. During the conference, “Hematology Frontier” specially invited Dr. Christian Chabannon from the Paoli-Calmettes Institute in Marseille, France, to…
-
Dr. Frédéric Millot: Future Directions in the Treatment of Chronic Myeloid Leukemia (CML) in Children
Recently, the 11th Sino-French Hematology Academic Conference, organized by the Chinese Medical Doctor Association, was successfully held in Tianjin, attracting hundreds of top experts and scholars in the field of hematology from China and abroad. During the conference, Dr. Frédéric Millot from the University Hospital of Poitiers, France, was invited by “Hematology Frontier” to share…
-
Dr. Lanfang Li and Dr. Weiyun Zhuang Discuss Mycosis Fungoides and Sézary Syndrome
The 5th Tianjin International Lymphoma Academic Conference, serving as an academic platform to foster international academic exchange and cooperation, has actively played its role as a bridge, facilitating in-depth exchange and collaboration in the field of international lymphoma. During the conference, “Hematology Frontier” specially invited Dr. Lanfang Li from the Tianjin Medical University Cancer Institute…
-
Dr. Lihua Qiu and Dr. Swaminathan Iyer Discuss the Latest Advances and Optimal Strategies for Peripheral T-Cell Lymphoma Treatment
The 5th Tianjin International Lymphoma Academic Conference, serving as an academic platform to foster international academic exchange and cooperation, has actively played its role as a bridge, facilitating in-depth exchange and collaboration in the field of international lymphoma. During the conference, “Hematology Frontier” specially invited Dr. Lihua Qiu from Tianjin Medical University Cancer Institute and…
-
STTT | Breakthrough in Kidney Cancer by Academician Xu Zhang’s Team! Neoadjuvant Regimen of Toripalimab Combined with Axitinib Assists RCC Patients with Tumor Thrombus Downstaging
Radical nephrectomy combined with venous tumor thrombus resection is the preferred treatment for renal cell carcinoma (RCC) with inferior vena cava tumor thrombus (IVC-TT) and can significantly improve patient prognosis. Preoperative neoadjuvant therapy aimed at reducing tumor thrombus level and grade is of great importance in reducing perioperative risks. Recently, the NEOTAX study, led by…
-
Dr. Jiuda Zhao’s Study in JCO Highlights Electroacupuncture’s Impact on Triple Antiemetic Therapy for Chemotherapy
Research Title: Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial Dr. Jiuda Zhao：This is the first study to integrate…
-
Dr. Jiuda Zhao Publishes Breakthrough Study in JCO, Demonstrating Electroacupuncture’s Significant Impact on Triple Antiemetic Therapy for Highly Emetogenic Chemotherapy
Recently, the team led by Dr. Jiuda Zhao at the Breast Disease Diagnosis and Treatment Center of Qinghai University Affiliated Hospital published their latest research findings in the Journal of Clinical Oncology (JCO), with an impact factor of 42.10. This study is the first to combine the current standard triple antiemetic therapy with electroacupuncture (EA)…
-
CSCO 2024 | Dr. Feng Shen: Witnessing CSCO’s Glorious Journey, Contributing to the Advancement of Personalized Surgical Treatment for Hepatobiliary Tu
Growing Together with CSCO Witnessing the Glorious Growth of CSCO and Contributing to the Development of the Hepatocellular Carcinoma Expert Committee Dr. Feng Shen: My mentor, Academician Wu Mengchao, was…
Connecting Medical Expertise through Media